1. Home
  2. CNTA vs BANR Comparison

CNTA vs BANR Comparison

Compare CNTA & BANR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • BANR
  • Stock Information
  • Founded
  • CNTA 2020
  • BANR 1890
  • Country
  • CNTA United Kingdom
  • BANR United States
  • Employees
  • CNTA N/A
  • BANR N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • BANR Major Banks
  • Sector
  • CNTA Health Care
  • BANR Finance
  • Exchange
  • CNTA Nasdaq
  • BANR Nasdaq
  • Market Cap
  • CNTA 2.3B
  • BANR 2.6B
  • IPO Year
  • CNTA 2021
  • BANR 1995
  • Fundamental
  • Price
  • CNTA $17.50
  • BANR $66.02
  • Analyst Decision
  • CNTA Strong Buy
  • BANR Buy
  • Analyst Count
  • CNTA 7
  • BANR 6
  • Target Price
  • CNTA $23.71
  • BANR $66.60
  • AVG Volume (30 Days)
  • CNTA 581.0K
  • BANR 229.4K
  • Earning Date
  • CNTA 11-12-2024
  • BANR 01-22-2025
  • Dividend Yield
  • CNTA N/A
  • BANR 2.88%
  • EPS Growth
  • CNTA N/A
  • BANR N/A
  • EPS
  • CNTA N/A
  • BANR 4.78
  • Revenue
  • CNTA $6,853,000.00
  • BANR $593,391,000.00
  • Revenue This Year
  • CNTA N/A
  • BANR N/A
  • Revenue Next Year
  • CNTA N/A
  • BANR $4.06
  • P/E Ratio
  • CNTA N/A
  • BANR $13.87
  • Revenue Growth
  • CNTA N/A
  • BANR N/A
  • 52 Week Low
  • CNTA $6.65
  • BANR $42.00
  • 52 Week High
  • CNTA $18.97
  • BANR $78.05
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 53.43
  • BANR 37.62
  • Support Level
  • CNTA $15.45
  • BANR $65.84
  • Resistance Level
  • CNTA $18.00
  • BANR $67.65
  • Average True Range (ATR)
  • CNTA 1.14
  • BANR 2.45
  • MACD
  • CNTA -0.05
  • BANR -0.43
  • Stochastic Oscillator
  • CNTA 76.78
  • BANR 19.20

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

Share on Social Networks: